Lipoxins and lipoxin analogs in asthma

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 73, Issue 3-4, 2005, Pages 231-237

  Levy, B D ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DEXAMETHASONE; GLUCOCORTICOID; LIPOXIN; LIPOXIN A; MONTELUKAST; PEPTIDOLEUKOTRIENE; RECEPTOR BLOCKING AGENT; STEROID;

ARACHIDONIC ACID METABOLISM; ASTHMA; CELL TYPE; CLINICAL TRIAL; CYSTIC FIBROSIS; DISEASE SEVERITY; HOMEOSTASIS; HUMAN; INFLAMMATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; SIGNAL TRANSDUCTION;

EID: 24344469198     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2005.05.010     Document Type: Article

References (37)

1. W.W. Busse, and R.F. Lemanske Jr. Asthma N Engl. J. Med. 344 2001 350 362
2. Anonymous Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society Am. J. Respir. Crit. Care Med. 162 2000 2341 2351
3. C. Lamblin, P. Gosset, and I. Tillie-Leblond Bronchial neutrophilia in patients with noninfectious status asthmaticus Am. J. Respir. Crit. Care Med. 157 1998 394 402
4. J. Bousquet, P.K. Jeffery, W.W. Busse, M. Johnson, and A.M. Vignola Asthma. From bronchoconstriction to airways inflammation and remodeling Am. J. Respir. Crit. Care Med. 161 2000 1720 1745
5. C. Nathan Points of control in inflammation Nature 420 2002 846 852
6. S.T. Holgate, P. Lackie, S. Wilson, W. Roche, D. Davies, Bronchial epithelium as a key regulator of airway allergen sensitization and remodeling in asthma, Am. J. Respir. Crit. Care Med. 162 (2000) S113-117.
7. B. Samuelsson, From studies of biochemical mechanisms to novel biological mediators: prostaglandin endoperoxides, thromboxanes and leukotrienes, Les Prix Nobel: Nobel Prizes, Presentations, Biographies and Lectures, Almqvist and Wiksell, Stockholm, 1982, pp. 153-174.
8. J.M. Drazen, E. Israel, and P.M. O'Byrne Treatment of asthma with drugs modifying the leukotriene pathway N. Engl. J. Med. 340 1999 197 206
9. 4 Clin. Biochem. 23 1990 459 468
10. A.M. Tager, S.K. Bromley, and B.D. Medoff, Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment Nat. Immunol. 4 2003 982 990
11. E. Baraldi, S. Carraro, and R. Alinovi Cysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbations Thorax 58 2003 505 509
12. S.A. Green, M.P. Malice, W. Tanaka, C.A. Tozzi, and T.F. Reiss Increase in urinary leukotriene LTE4 levels in acute asthma: correlation with airflow limitation Thorax 59 2004 100 104
13. C.N. Serhan Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution Prostag. Other Lipid Mediat. 68-69 2002 433 455
14. D.W. Gilroy, T. Lawrence, M. Perretti, and A.G. Rossi Inflammatory resolution: new opportunities for drug discovery Nat. Rev. Drug Discovery 3 2004 401 416
15. B.D. Levy, G.T. De Sanctis, and P.R. Devchand Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4) Nat. Med. 8 2002 1018 1023
16. C.N. Serhan, M. Hamberg, and B. Samuelsson Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes Proc. Natl. Acad. Sci. USA 81 1984 5335 5339
17. J.A. Hunter, W.E. Finkbeiner, J.A. Nadel, E.J. Goetzl, and M.J. Holtzman Predominant generation of 15-lipoxygenase metabolites of arachidonic acid by epithelial cells from human trachea Proc. Natl. Acad. Sci. USA 82 1985 4633 4637
18. C.N. Serhan, U. Hirsch, J. Palmblad, and B. Samuelsson Formation of lipoxin A by granulocytes from eosinophilic donors FEBS Lett. 217 1987 242 246
19. C.N. Serhan, S. Fiore, D.A. Brezinski, and S. Lynch Lipoxin A4 metabolism by differentiated HL-60 cells and human monocytes: conversion to novel 15-oxo and dihydro products Biochemistry 32 1993 6313 6319
20. C.B. Clish, B.D. Levy, N. Chiang, H.H. Tai, and C.N. Serhan Oxidoreductases in lipoxin A4 metabolic inactivation: a novel role for 15-oxoprostaglandin 13-reductase/leukotriene B4 12-hydroxydehydrogenase in inflammation J. Biol. Chem. 275 2000 25372 25380
21. C.B. Clish, J.A. O'Brien, K. Gronert, G.L. Stahl, N.A. Petasis, and C.N. Serhan Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo Proc. Natl. Acad. Sci. USA 96 1999 8247 8252
22. B.D. Levy, C.B. Clish, B. Schmidt, K. Gronert, and C.N. Serhan Lipid mediator class switching during acute inflammation: signals in resolution Nat. Immunol. 2 2001 612 619
23. K. Fukunaga, P. Kohli, C. Bonnans, L.E. Fredenburgh, and B.D. Levy Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury J. Immunol. 174 2005 1 in press
24. G. Canny, O. Levy, and G.T. Furuta Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia Proc. Natl. Acad. Sci. USA 99 2002 3902 3907
25. M. Perretti, N. Chiang, and M. La Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor Nat Med 8 2002 1296 1302
26. B.D. Levy, V.V. Fokin, J.M. Clark, M.J. Wakelam, N.A. Petasis, and C.N. Serhan Polyisoprenyl phosphate (PIPP) signaling regulates phospholipase D activity: a 'stop' signaling switch for aspirin-triggered lipoxin A4 FASEB J. 13 1999 903 911
27. T. Ohira, G. Bannenberg, and M. Arita A stable aspirin-triggered lipoxin A4 analog blocks phosphorylation of leukocyte-specific protein 1 in human neutrophils J. Immunol. 173 2004 2091 2098
28. J. Shen, E. Herderick, J.F. Cornhill, E. Zsigmond, S. Kim H-, H. Kuhn, N.V. Guervara, and L. Chan Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development J. Clin. Invest. 98 1996 2201 2208
29. C.N. Serhan, A. Jain, and S. Marleau Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators J. Immunol. 171 2003 6856 6865
30. P.R. Devchand, M. Arita, and S. Hong Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense FASEB J. 17 2003 652 659
31. S.E. Dahlen, L. Franzen, and J. Raud Actions of lipoxin A4 and related compounds in smooth muscle preparations and on the microcirculation in vivo Adv. Exp. Med. Biol. 229 1988 107 130
32. N. Chiang, K. Gronert, C.B. Clish, J.A. O'Brien, M.W. Freeman, and C.N. Serhan Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion J. Clin. Invest. 104 1999 309 316
33. T.H. Lee, A.E. Crea, and V. Gant Identification of lipoxin A4 and its relationship to the sulfidopeptide leukotrienes C4, D4, and E4 in the bronchoalveolar lavage fluids obtained from patients with selected pulmonary diseases Am. Rev. Respir. Dis. 141 1990 1453 1458
34. P.E. Christie, B.W. Spur, and T.H. Lee The effects of lipoxin A4 on airway responses in asthmatic subjects Am. Rev. Respir. Dis. 145 1992 1281 1284
35. M. Sanak, B.D. Levy, and C.B. Clish Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics Eur. Respir. J. 16 2000 44 49
36. C. Bonnans, I. Vachier, C. Chavis, P. Godard, J. Bousquet, and P. Chanez Lipoxins are potential endogenous antiinflammatory mediators in asthma Am. J. Respir. Crit. Care Med. 165 2002 1531 1535
37. C.L. Karp, L.M. Flick, and K.W. Park Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway Nat. Immunol. 5 2004 388 392